Thromboprophylaxis Outcome in Childhood SARS-CoV-2 Infection: A Single-Center Experience
- 27 September 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 45 (1) , e97-e102
Abstract
Background: The SARS-CoV-2 infection has been associated with potentially endothelial damage and coagulation cascade activation that cause thrombosis. There is limited information on thrombosis and anticoagulant therapy in children with coronavirus disease 2019 (COVID-19). Aims: This study evaluates the outcome of thromboprophylaxis in children younger than 18-year old with COVID-19 infection. Methods: A retrospective study was conducted on 184 hospitalized pediatric patients with confirmed COVID-19 infection. A designed questionnaire was made to collect all demographic, clinical, and laboratory data. According to World Health Organization, the patients were classified as asymptomatic/mild, moderate, severe, and critically ill. Results: The mean age of the patients was 7.04±5.9 (1 wk to younger than 18 y). Overall, 33 patients received anticoagulant therapy. All patients who passed away (n=19) belonged to the critical group. One patient (1.28%) was complicated with deep vein thrombosis despite taking thromboprophylaxis, and 1 (1.28%) with pulmonary thromboembolism while the patient did not take an anticoagulant. Conclusions: Our data showed a lower rate of thrombosis (1.4%) than adult patients with COVID-19. It may underline the role of anticoagulants in moderate to severe/critically ill children with COVID-19 infection. Expert opinion and personal experience are necessary, while we have a significant knowledge gap in understanding COVID-19-associated coagulopathy and thrombotic risk in children.Keywords
This publication has 26 references indexed in Scilit:
- Disease severity classification and COVID-19 outcomes, Republic of KoreaBulletin of the World Health Organization, 2020
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19Thrombosis Research, 2020
- Epidemiology of COVID-19 Among Children in ChinaPediatrics, 2020
- Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis, 2020
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in ChinaJAMA, 2020
- SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristicsJournal of the Formosan Medical Association, 2020
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family clusterThe Lancet, 2020
- Peripherally inserted central catheters lead to a high risk of venous thromboembolism in childrenBlood, 2020